PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study

Fiona Hegi-Johnson; Stacey E Rudd; Christian W Wichmann; Tim Akhurst; Peter Roselt; Sandra Sursock; Jenny Trinh; Thomas John; Lisa Devereux; Paul S Donnelly; Rodney J Hicks; Andrew M Scott; Daniel Steinfort; Stephen Fox; Benjamin Blyth; Sagun Parakh; Gerard G Hanna; Jason Callahan; Kate Burbury; Michael MacManus

doi:10.1016/j.ijrobp.2023.05.019

PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study

Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):675-682. doi: 10.1016/j.ijrobp.2023.05.019. Epub 2023 Jul 3.

Authors

Fiona Hegi-Johnson¹, Stacey E Rudd², Christian W Wichmann³, Tim Akhurst⁴, Peter Roselt⁵, Sandra Sursock⁶, Jenny Trinh⁶, Thomas John⁷, Lisa Devereux⁸, Paul S Donnelly², Rodney J Hicks⁹, Andrew M Scott³, Daniel Steinfort¹⁰, Stephen Fox¹¹, Benjamin Blyth¹², Sagun Parakh¹³, Gerard G Hanna⁸, Jason Callahan⁵, Kate Burbury¹⁴, Michael MacManus¹²

Affiliations

¹ Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: fiona.hegi-johnson@petermac.org.
² School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia.
³ Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne, Melbourne, Victoria, Australia.
⁴ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁵ Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁶ Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁷ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁸ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
⁹ Department of Medicine, St Vincent's Medical School, University of Melbourne, Melbourne, Victoria, Australia; Department of Medicine, Central Medical School, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
¹⁰ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Respiratory Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
¹¹ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
¹² Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
¹³ Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
¹⁴ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia; Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

PMID: 37406824
DOI: 10.1016/j.ijrobp.2023.05.019

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung* / diagnostic imaging
Humans
Lung Neoplasms* / diagnostic imaging
Positron Emission Tomography Computed Tomography / methods
Positron-Emission Tomography / methods

Substances

B7-H1 Antigen